← Eichor
Study identifier: NCT06334562 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery

Condition: Neuromuscular Blockade  ·  Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine

PhaseNA
Planned participants80
Who can joinAll sexes, 19 Years to 75 Years
Healthy volunteersYes

About this study

This study aims to compare the use of sugammadex (domestic) and neostigmine for antagonism after thoracic surgery, and observe the effect of sugammadex (domestic) on neuromuscular blockade antagonism after thoracic surgery, in order to provide a basis for optimizing the use of muscle relaxants and their antagonists during anesthesia.

This description comes directly from the study's public registry record.

Talk to the study team

JianHong Xu  ·  86-18867961109  ·  xujh1969@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Fourth Affiliated Hospital of Zhejiang University School of MedicineYiwu, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06334562